Australia's TGA has not reviewed or approved retatrutide
In a March 3, 2026 press announcement (FDA.gov press announcement, March 3, 2026), the FDA issued warning letters to 30 telehealth companies specifically for making claims that implied sameness with FDA-approved products - a category-wide compliance signal every buyer should understand
glucose-dependent insulinotropic polypeptide
Building muscle helps boost your metabolism, supports blood sugar balance, and makes your body more sensitive to insulin over time
You forget to put the vial back after your injection
To meet the demand, health providers like Hims & Hers had jumped on the opportunity to provide compounded versions of the weight-loss medications, which haven't been on the market long enough to have generic equivalents